Nasdaq:US$40.98 (-0.83) | HKEX:HK$70.85 (-6.75) | AIM:£5.92 (+0.14)
新闻中心及演示文稿
上一篇文章   |   下一篇文章
演示文稿, 科学出版物 | 2010-11-30

Randomised clinical trial: herbal extract HMPL-004 in active ulcerative colitis – a double-blind comparison with sustained release mesalazine (Alimentary Pharmacology and Therapeutics 2011)